Crystal form of baxdrostat, and preparation method therefor and use thereof

Abstract

A new crystal form of Baxdrostat, and a preparation method therefor, a pharmaceutical composition containing the crystal form, and the use of the crystal form in the preparation of an aldosterone synthase inhibitor drug and a drug for treating hypertension, primary aldosteronism, and chronic kidney disease.

Dependencies are inferred from the claim text.